Should Drug Companies Be Advertising to Consumers?
(By Paula Span for KFF Health News) Tamar Abrams had a lousy couple of years in 2022 and ’23. Both
Read More
Part D/Prescription Drugs
BCBS Michigan scores $147M in savings through biosimilars
(By: Elizabeth Casolo for Becker’s Hospital Review) BCBS Michigan saved $67 million and $80 million in 2024 and 2025, respectively,
Read More
12 drugs in shortage
(By: Ella Jeffries for Becker’s Hospital Review) The number of active drug shortages has declined sharply since June, according to
Read MoreThe IRA Has Improved Coverage of Drugs Selected for Medicare Price Negotiation
(Authors: Juliette Cubanski and Nolan Sroczynski for The Kaiser Family Foundation Published: Feb 11, 2026) The Medicare Drug Price Negotiation
Read More
Molina to drop Medicare Advantage prescription drug plans in 2027
(By: Jakob Emerson for Becker’s Hospital Review) Molina Healthcare will exit the Medicare Advantage Part D business in 2027, the
Read More
What experts say individuals should consider before changing Medicare Advantage plans.
We are now past the halfway mark of the 2026 Medicare Advantage open enrollment period. The Medicare Advantage Open Enrollment
Read MoreWhite House unveils TrumpRx website for medication discounts
(By Sydney Lupkin for NPR) The Trump administration finally has unveiled TrumpRx.gov, a website for consumers to find discounts on
Read More
TrumpRx launch delayed
(By: Ella Jeffries for Becker’s Hospital Review) The Trump administration has delayed the launch of TrumpRx.gov, a website designed to connect
Read More
Helping you understand the Medicare’s ins and outs
Medicare is made up of different parts, each serving distinct healthcare needs. There are four main parts of Medicare: Part
Read More
CMS names 15 medications for 2028 price negotiation cycle
(By: Paige Twenter for Becker’s Hospital Review) CMS will negotiate the prices for Trulicity, Biktarvy and 13 other high-cost medications
Read More